Related scientific articles (all)

Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox.

Authors : Dubsky P, Pinker K, Cardoso F, Montagna G, Ritter M, Denkert C, Rubio IT, de Azambuja E, Curigliano G, Gentilini O, Gnant M, Günthert A, Hauser N, Heil J, Knauer M, Knotek-Roggenbauerc M, Knox S, Kovacs T, Kuerer HM, Loibl S, Mannhart M, Meattini I, Penault-Llorca F, Radosevic-Robin N, Sager P, Steyerova P, Tausch C, Peeters MTFDV, Weber WP, Cardoso MJ, Poortmans P
Year : 2021
Journal : Lancet Oncol
Volume : 22
Pages : e18-e28

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis.

Authors : Dumont L, Salaroli A, Dal Lago L, Gil T, Pepersack T
Year : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pages : 002425

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer.

Authors : Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD, Ferollà P, Herrmann K, Karamitopoulou E, Neuzillet C, Orsi F, Seppänen H, Torchio M, Valenti D, Zamboni G, Zins M, Costa A, Poortmans P
Year : 2021
Journal : Cancer Treat Rev
Pages : 102208

Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.

Authors : Wrona E, Potemski P, Sclafani F, Borowiec M
Year : 2021
Journal : Arch Immunol Ther Exp (Warsz)
Volume : 69
Pages : 2

Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment.

Authors : Boisson A, Noël G, Saiselet M, Rodrigues-Vitória J, Thomas N, Fontsa ML, Sofronii D, Naveaux C, Duvillier H, Craciun L, Larsimont D, Awada A, Detours V, Willard-Gallo K, Garaud S
Year : 2021
Journal : Front Mol Biosci
Volume : 8
Pages : 673042

Imaging and clinical correlates with regorafenib in metastatic colorectal cancer.

Authors : Khan K, Cascinu S, Cunningham D, Kim SY, Oki E, Seery T, Shen L, Siena S, Tournigand C, Turhal NS, Hendlisz A
Year : 2020
Journal : Cancer Treat Rev
Volume : 86
Pages : 102020

Palbociclib safety and efficacy beyond Ribociclib-induced liver toxicity in metastatic hormone-receptors positive breast cancer patient.

Authors : Farhat F, Tarabaih M, Kanj A, Aoun M, Kattan J, Assi T, Awada A
Year : 2020
Journal : Anticancer Drugs
Volume : 31
Pages : 85-89

Pimasertib Versus Dacarbazine in Patients With Unresectable <i>NRAS</i>-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover.

Authors : Lebbé C, Dutriaux C, Lesimple T, Kruit W, Kerger J, Thomas L, Guillot B, Braud F, Garbe C, Grob JJ, Loquai C, Ferraresi V, Robert C, Vasey P, Conry R, Isaacs R, Espinosa E, Schueler A, Massimini G, Dréno B
Year : 2020
Journal : Cancers (Basel)
Volume : 12

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.

Authors : Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K
Year : 2020
Journal : Ann Oncol
Volume : 31
Pages : 171-190

Nutrition education in medical schools (NEMS). An ESPEN position paper.

Authors : Cuerda C, Muscaritoli M, Donini LM, Baqué P, Barazzoni R, Gaudio E, Jezek D, Krznaric Z, Pirlich M, Schetgen M, Schneider S, Vargas JA, Van Gossum A
Year : 2020
Journal : Clin Nutr
Volume : 39
Pages : 2938-2939

Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.

Authors : Caparica R, Bruzzone M, Hachem GE, Ceppi M, Lambertini M, Glasberg J, de Azambuja E, Van Laethem JL, Hendlisz A
Year : 2020
Journal : Crit Rev Oncol Hematol
Volume : 149
Pages : 102940

Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors.

Authors : Piccart-Gebhart M, Hilbers FS, Bliss JM, Caballero C, Frank ES, Renault P, Naït Kaoudjt R, Schumacher E, Spears PA, Regan MM, Gelber Rd, Davidson NE, Norton L, Winer EP
Year : 2020
Journal : J Clin Oncol
Volume : 38
Pages : 4120-4129

Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index.

Authors : Desmedt C, Fornili M, Clatot F, Demicheli R, De Bortoli D, Di Leo A, Viale G, de Azambuja E, Crown J, Francis PA, Sotiriou C, Piccart-Gebhart M, Biganzoli E
Year : 2020
Journal : J Clin Oncol
Volume : 38
Pages : 2883-2891

Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice.

Authors : Bregni G, Akin Telli T, Camera S, Deleporte A, Moretti L, Bali MA, Liberale G, Holbrechts S, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Treat Rev
Volume : 83
Pages : 101948

Oncology care: keep it going, Learn – Improve – Act (white paper BE, IPSEN, ALL-BE-000191- Oct 2020)

Authors : Awada A, Ameye F, Bangma CH, Bloemendal H, van Damme J, Gennigens C, de Herder W, Lybaert W, De Meerleer G, Peeters M, Romijn JA, Rottey S, Sedelaar JP, Seront E, Stouthard JM, Suelmann B, Tuytten T, Valk G, De Vries S, Willemse P
Year : 2020
Journal : IPSEN
Volume : -
Pages : -

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.

Authors : Franzoi MA, Vandeputte C, Eiger D, Caparica R, Brandão M, de Angelis C, Hendlisz A, Awada A, Piccart-Gebhart M, de Azambuja E
Year : 2020
Journal : Breast Cancer Res Treat
Volume : 181
Pages : 199-209

Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. <i>

Authors : Krayem M, Aftimos P, Najem A, Hooven TVD, Berg AVD, Hovestad-Bijl L, Wijn R, Hilhorst R, Ruijtenbeek R, Sabbah M, Kerger J, Awada A, Journe F, Ghanem G
Year : 2020
Journal : Cancers (Basel)
Volume : 12

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.

Authors : Saini KS, Lanza C, Romano M, de Azambuja E, Cortes J, de Las Heras B, de Castro J, Lamba Saini M, Loibl S, Curigliano G, Twelves C, Leone M, Patnaik MM
Year : 2020
Journal : Br J Cancer
Volume : 123
Pages : 694-697

Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer.

Authors : Pondé N, Ameye L, Lambertini M, Paesmans M, Piccart-Gebhart M, de Azambuja E
Year : 2020
Journal : Eur J Cancer
Volume : 126
Pages : 65-73

Clinical management of first-line advanced triple-negative breast cancer patients

Authors : Rediti M, Punie K, de Azambuja E, Naert E, Taylor D, Duhoux FP, Denys H, Awada A, Wildiers H, Ignatiadis M
Year : 2020
Journal : Belgian J Medical Oncology
Volume : 14(7)
Pages : 333-338